insights_auto
Why is CRSP down 3.65%?
Dive Deeperchevron_right
CRSP:NASDAQ
Crispr Therapeutics AG
$50.44
arrow_downward
-3.65%(-1.91) 1D
$51.08
arrow_upward
+1.27% (+0.64)todayPre-market
Closed: Oct 8, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CRSP...
Open
$51.51
High
$53.54
Low
$50.02
Mkt. cap
4.88B
Avg. vol.
1.56M
Volume
2.48K
52-wk high
$78.34
52-wk low
$44.12
EPS
-$4.76
Beta
1.45
Shares outstanding
96.69M
No. of employees
393
Open
$51.51
High
$53.54
Low
$50.02
Mkt. cap
4.88B
Avg. vol.
1.56M
Volume
2.48K
52-wk high
$78.34
52-wk low
$44.12
EPS
-$4.76
Beta
1.45
Shares outstanding
96.69M
No. of employees
393
News stories
From web sources and news partners
MarketBeat
·
3 hours ago
CRISPR Therapeutics AG (NASDAQ:CRSP) Stock Rated "Moderate Buy" by Sell-Side Brokerages
Investing.com Canada
·
11 hours ago
Form 4 CRISPR Therapeutics AG For: 8 October By Investing.com
Stock Titan
·
12 hours ago
Counsel exercises options and sells 1,990 CRISPR Therapeutics (CRSP) shares under a trading plan.
Zacks
·
18 hours ago
AbbVie's Temab-A Gets Two FDA Breakthrough Therapy Tags in Cancer
Profile
CRISPR Therapeutics AG is a Swiss–American biotechnology company headquartered in Zug, Switzerland. The company does business as CRISPR Therapeutics, Inc. in the United States. It was one of the first companies formed to utilize the CRISPR gene editing platform to develop medicines for the treatment of various rare and common diseases. The company has approximately 500 employees and has offices in Zug, Switzerland; Boston, Massachusetts; San Francisco, California; and London, United Kingdom. Its manufacturing facility in Framingham, Massachusetts, won the Facilities of the Year Award award in 2022. The company’s lead program, exagamglogene autotemcel, or exa-cel, was granted regulatory approval by the US Food and Drug Administration in December 2023. Wikipedia
About Crispr Therapeutics AG
CEOSamarth Kulkarni
Employees393
Founded2013
HeadquartersZug, Zug, Switzerland
SectorBiotechnology
Websitecrisprtx.com